PRTK - Paratek Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03 revenue of $31.24M misses by $0.39M
2023-05-09 16:35:49 ET
- Paratek Pharmaceuticals press release ( NASDAQ: PRTK ): Q1 GAAP EPS of -$0.35 beats by $0.03 .
- Revenue of $31.24M (+25.7% Y/Y) misses by $0.39M .
- 2023 revenue guidance of $143 to $158 million vs $158.97M consensus
- Consistent with our commitment to accelerate our pathway to profitability, 2023 R&D and SG&A expense guidance is $160 to $170 million
For further details see:
Paratek Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03, revenue of $31.24M misses by $0.39M